Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Decompensation”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Large-scale testing (Phase 3)UnknownNCT06106971
What this trial is testing

Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

Who this might be right for
Gastric Varices BleedingLiver Decompensation
Kaohsiung Veterans General Hospital. 68
Not applicableStudy completedNCT02457637
What this trial is testing

Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study

Who this might be right for
Liver Failure, Acute on Chronic
Hai Li 2,600
Not applicableLooking for participantsNCT06855056
What this trial is testing

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

Who this might be right for
Liver CirrhosisDecompensated Cirrhosis of Liver
European Foundation for Study of Chronic Liver Failure 189
Large-scale testing (Phase 3)Temporarily pausedNCT02271295
What this trial is testing

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients

Who this might be right for
Cirrhosis
Assistance Publique - Hôpitaux de Paris 16
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06823713
What this trial is testing

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

Who this might be right for
End-stage Liver Disease (ESLD)Cirrhosis, LiverCirrhosis, Decompensated+5 more
Resolution Therapeutics Limited 30
Testing effectiveness (Phase 2)UnknownNCT04620148
What this trial is testing

TAK-242 in Patients With Acute Alcoholic Hepatitis

Who this might be right for
Acute-On-Chronic Liver Failure
Akaza Bioscience Ltd 100
Testing effectiveness (Phase 2)Ended earlyNCT06987968
What this trial is testing

See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis
Genfit 3
Post-approval studies (Phase 4)Looking for participantsNCT07322237
What this trial is testing

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Who this might be right for
Cirrhotic CardiomyopathyEmpagliflozinCardiometabolic Risk Factors+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 400
Testing effectiveness (Phase 2)Study completedNCT01687257
What this trial is testing

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Who this might be right for
Hepatitis CCirrhosisPortal Hypertension+1 more
Gilead Sciences 50
Not applicableUnknownNCT03084185
What this trial is testing

Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .

Who this might be right for
Cirrhosis
University of Modena and Reggio Emilia 200
Not applicableNot Yet RecruitingNCT07185360
What this trial is testing

Liver Diseases: Extracellular Vesicles as Biomarkers

Who this might be right for
Liver Diseases
Assistance Publique - Hôpitaux de Paris 845
Not applicableStudy completedNCT03641872
What this trial is testing

A Validation Cohort for ACLF Diagnosis and Prognosis

Who this might be right for
Liver Failure, Acute on ChronicLiver Dysfunction
Hai Li 1,370
Not applicableStudy completedNCT02084160
What this trial is testing

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Who this might be right for
Chronic Liver Disease
Meridian Bioscience, Inc. 579
Large-scale testing (Phase 3)Active Not RecruitingNCT05071716
What this trial is testing

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 524
Not applicableNot Yet RecruitingNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,800
Testing effectiveness (Phase 2)Study completedNCT07033533
What this trial is testing

Allopurinol and Pathogenesis of Cirrhosis

Who this might be right for
Cirrhoses, Liver
Tanta University 100
Not applicableStudy completedNCT00341705
What this trial is testing

The Second Multicenter Hemophilia Cohort Study

Who this might be right for
Liver DecompensationHepatocellular CarcinomaNon-Hodgkin Lymphoma
National Cancer Institute (NCI) 2,565
Testing effectiveness (Phase 2)Ended earlyNCT06082843
What this trial is testing

Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Who this might be right for
Hypertension, PortalLiver Cirrhosis
Boehringer Ingelheim 22
Large-scale testing (Phase 3)Study completedNCT01157845
What this trial is testing

Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis

Who this might be right for
Cirrhosis
Virginia Commonwealth University 165
Load More Results